Sargent Investment Group, LLC

Position in ARDX — Ardelyx, Inc.

CIK 1766157 BETHESDA, MD

Position in ARDX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$86,855

+$5,235 QoQ

Shares Held

14,500

+3.6% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Sargent Investment Group, LLC holds $8,795,985 across 5 Biotechnology names. ARDX ranks #3 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	179,025	$7,678,382
2	MDWD	MediWound Ltd.	59,481	$958,238
3	ARDX	Ardelyx, Inc. This page	14,500	$86,855
4	NAGE	Niagen Bioscience, Inc.	15,000	$66,150
5	MTNB	Matinas BioPharma Holdings, Inc.	12,720	$6,360

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$86,855	14,500	+3.6%	Shares	Sole	2026-05-11
2025-12-31	$81,620	14,000	-29.4%	Shares	Sole	2026-02-13
2023-12-31	$122,877	19,819	-44.9%	Shares	Sole	2024-02-05
2023-09-30	$146,622	35,937	0.0%	Shares	Sole	2023-11-13
2023-06-30	$121,826	35,937	+5.8%	Shares	Sole	2023-07-31
2023-03-31	$162,625	33,951	+51.0%	Shares	Sole	2023-05-02
2022-12-31	$64,076	22,483	-61.3%	Shares	Sole	2023-01-31
2022-09-30	$69,150	58,110	+440.8%	Shares	Sole	2022-10-27
2021-09-30	$14,183	10,745	+5.3%	Shares	Sole	2021-11-12
2021-03-31	$67,550	10,204	+0.3%	Shares	Sole	2021-05-04
2020-12-31	$65,845	10,177	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.